MAPT and Alzheimer disease: Studies have also shown that blocking the adhesion mechanisms controlling leukocyte–endothelial interactions can inhibit both Aβ deposition and tau hyperphosphorylation and eventually reduce memory loss in AD models (Chakraborty et al., 2017).